Search For "clinical trial"
Clinical trials indicate India's vaccines will be effective agains
Updated : 6 days, 18 hours ago IST
Thiruvananthapuram (Kerala) [India], February 19 (ANI): The Indian Council of Medical Research (ICMR) on Thursday said interim results of the ongoing clinical trials indicated that the indigenous COVID-19 vaccines would be effective against the mutated virus strains reported from the Unit
Read More
Serum Institute seeks DCGI nod for clinical trials of COVID-19 vac
Updated : 3 weeks, 5 days ago IST
New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'COVOVAX', a COVID-19 vacci
Read More
COVAXIN shows high safety, immunogenicity during phase 1 clinical
Updated : 1 month ago IST
New Delhi [India], January 22 (ANI): In a remarkable finding, India's indigenous Covid-19 vaccine--COVAXIN developed by the Bharat Biotech and Indian Council of Medical Research (ICMR) has shown high safety and immunogenicity during the phase 1 clinical trial, according to the findings of th
Read More
UAE authorises emergency use of Russia's Sputnik V vaccine against
Updated : 1 month ago IST
Abu Dhabi [UAE], January 21 (ANI/Sputnik): The United Arab Emirates (UAE) authorized emergency use of Russia's Sputnik V vaccine against the coronavirus, the Russian Direct Investment Fund (RDIF) confirmed on Thursday, noting that Phase III clinical trials were still ongoing in the UAE.
Read More
Chloroquine Nasal drops have potential to prevent covid-19 infecti
Updated : 1 month ago IST
New Delhi [India] January 21 (ANI): A study by the doctors of All India Institute of Medical Sciences (AIIMS), New Delhi reveals that Chloroquine (CQN), when administered as nasal drops, has the potential to prevent COVID-19 infection if administered before the infection is established.
Read More
RML Resident Doctors' Association opposes Bharat Biotech's Covaxin
Updated : 1 month, 1 week ago IST
New Delhi [India] January 16 (ANI): As India started its vaccination drive against COVID-19 on Saturday, members of Resident Doctors' Association (RDA) at RML hospital here expressed doubts over Covaxin, saying there is "lack of complete trial".
Read More
Clinical trial finds vitamin D does not ward off colds, flu
Updated : 1 month, 1 week ago IST
Washington [US], January 14 (ANI): An Australian randomised controlled trial of vitamin D supplements, led by QIMR Berghofer Medical Research Institute has found they do not protect most people from developing colds, flu and other acute respiratory infections.
Read More
Sputnik V meets primary endpoint of safety in phase 2 clinical tri
Updated : 1 month, 2 weeks ago IST
Hyderabad (Telangana) [India], January 12 (ANI): Dr Reddy's Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from phase two clinical trial of Russia's Covid-19 vaccine Sputnik V and recommended phase three recruitment along with continui
Read More
Russian COVID vaccine Sputnik V meets primary safety endpoint in p
Updated : 1 month, 2 weeks ago IST
Hyderabad (Telangana) [India], January 11 (ANI): The Russian made Covid-19 vaccine Sputnik V has met the primary endpoint of safety in the phase-2 clinical trials in India and has been recommended to continue the clinical trial without any modifications, according to an official statement.
Read More
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phas
Updated : 1 month, 2 weeks ago IST
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced the successful completion of volunteer enrolment for phase-3 clinical trials of its indigenously manufactured COVID-19 vaccine 'Covaxin.'
Read More
Emergency use of vaccine is based on safety, immunogenicity data,
Updated : 1 month, 3 weeks ago IST
New Delhi [India], January 5 (ANI): The Indian Council of Medical Research (ICMR) director Dr Balram Bhargava on Tuesday said that in a pandemic situation, restricted emergency use of the vaccine is considered based on phase 2 safety and immunogenicity clinical trial data while phase thre
Read More
Bharat Biotech MD questions experts' silence over UK trials of Cov
Updated : 1 month, 3 weeks ago IST
New Delhi [India], January 4 (ANI): Coming down heavily on critics expressing doubts about the Bharat Biotech's indigenously developed coronavirus vaccine COVAXIN, the Hyderabad-based biotech major's managing director Dr Krishna Ella on Monday slammed the critics for targeting Indian clinica
Read More